Longwood Fund
VC · Boston · United States
Etapas
Región de inversión
Industrias
Perfil
Longwood Fund is a venture capital firm based in Boston, Massachusetts, known for creating and investing in science-driven companies addressing critical medical issues. The firm was co-founded by Christoph Westphal, who has a history of building and leading biotechnology firms. Longwood Fund operates with a team of seasoned professionals, often taking active roles in their portfolio companies, such as Co-Founding CEOs, CBOs, or Presidents. The firm focuses on the healthcare sector, particularly in biotechnology and pharmaceuticals. Its investment strategy targets early-stage companies innovating in areas like novel therapeutics and medical technologies, primarily within North America. The firm does not publicly disclose its total assets under management. Notable investments by Longwood Fund include Pyxis Oncology, Werewolf Therapeutics, TScan Therapeutics, and Pulmocide. These companies span innovative therapeutic development and biotechnologies. Additionally, Longwood Fund has been instrumental in co-founding significant ventures such as Immunitas Therapeutics and Be Biopharma.
Contactos (2)
| Nombre | Cargo | Teléfono | ||
|---|---|---|---|---|
| Partner | — | — | — | |
| Co-Founder & General Partner | — | — | — |
El nombre, email y teléfono se muestran en sombra. Suscribite para verlos completos.